Light Treatment of Symptomatic Vulvovaginitis
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Antimicrobials have helped in managing vaginal dysbiotic conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). However, their increasing inefficiency and rise in antimicrobial resistance (AMR) is a challenge and threat to public health. Therefore, this study will investigate the safety and efficacy of light as an antimicrobial to treat vulvovaginal infections.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:
• Age 18-45 years of age
• Normal gynecological status
• Diagnosed for BV or VVC
• Not pregnant
• No signs of other genital tract infections
Locations
Other Locations
Denmark
Odense University Hospital
RECRUITING
Odense C
Time Frame
Start Date: 2025-06
Estimated Completion Date: 2025-10
Participants
Target number of participants: 40
Treatments
Experimental: Treatment of BV with single session of light treatment.
A group of 10 patients will receive light therapy in single treatment session to evaluate its safety and efficacy.
Experimental: Treatment of BV with two sessions of light treatment.
A group of 10 patients will receive light therapy in two treatment sessions to evaluate its safety and efficacy.
Experimental: Treatment of VVC with single session of light treatment.
A group of 10 patients will receive light therapy in single treatment session to evaluate its safety and efficacy.
Experimental: Treatment of VVC with two sessions of light treatment.
A group of 10 patients will receive light therapy in two treatment sessions to evaluate its safety and efficacy.
Related Therapeutic Areas
Sponsors
Collaborators: Odense University Hospital
Leads: UVISA Health ApS